1. Home
  2. SAMG vs BSEM Comparison

SAMG vs BSEM Comparison

Compare SAMG & BSEM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Silvercrest Asset Management Group Inc.

SAMG

Silvercrest Asset Management Group Inc.

SELL

Current Price

$10.62

Market Cap

80.0M

Sector

Finance

ML Signal

SELL

Logo BioStem Technologies Inc. Common Stock

BSEM

BioStem Technologies Inc. Common Stock

N/A

Current Price

$2.08

Market Cap

76.9M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
SAMG
BSEM
Founded
2002
2006
Country
United States
United States
Employees
N/A
N/A
Industry
Investment Managers
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
80.0M
76.9M
IPO Year
2012
2026

Fundamental Metrics

Financial Performance
Metric
SAMG
BSEM
Price
$10.62
$2.08
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
95.3K
★ 159.4K
Earning Date
10-29-2026
11-12-2026
Dividend Yield
★ 7.88%
N/A
EPS Growth
N/A
★ N/A
EPS
★ 0.05
N/A
Revenue
★ $91,358,000.00
N/A
Revenue This Year
$1.56
N/A
Revenue Next Year
$7.04
$87.68
P/E Ratio
$213.20
★ N/A
Revenue Growth
N/A
N/A
52 Week Low
$9.09
$1.88
52 Week High
$16.16
$5.44

Technical Indicators

Market Signals
Indicator
SAMG
BSEM
Relative Strength Index (RSI) 61.46 29.74
Support Level $10.68 N/A
Resistance Level $11.61 $4.12
Average True Range (ATR) 0.37 0.32
MACD 0.03 -0.10
Stochastic Oscillator 77.14 9.91

Price Performance

Historical Comparison
SAMG
BSEM

About SAMG Silvercrest Asset Management Group Inc.

Silvercrest Asset Management Group Inc is a wealth management firm focused on providing financial advisory and related family office services to ultra-high net-worth individuals and institutional investors. It advises clients on traditional investment strategies focused on equities, fixed income, and cash, as well as non-traditional investment strategies including hedge funds, private equity funds, real estate, and commodities. The firm offers a full suite of complementary and customized family office services for families seeking comprehensive oversight of their financial affairs. The company derives revenues from Managed accounts, Silvercrest funds, Tax and family office services, and Fund administration. The firm generates the majority of its revenue from Managed Accounts.

About BSEM BioStem Technologies Inc. Common Stock

BioStem Technologies Inc is a regenerative biotechnology company focused on harnessing elements of perinatal tissue and the body's innate biology to repair or reverse damage caused by a broad range of degenerative diseases. The company develops, manufactures, and sells tissue allografts for the wound care market with a focus on the treatment of diabetic, pressure, and venous ulcers. Utilizing its proprietary BioRetain processing method, it manufactures perinatal tissue allografts. The company offers a comprehensive portfolio of high-quality brands that are trademarked and include VENDAJE AC, AmnioWrap2, and Others. The company generates key revenue from VENDAJE AC.

Share on Social Networks: